Article Details

Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and ...

Retrieved on: 2021-05-18 20:03:45

Tags for this article:

Click the tags to see associated articles and topics

Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and .... View article details on hiswai:

Excerpt

Sapience Therapeutics, Inc., is a privately held, clinical stage biotechnology company focused on discovering and developing peptide-based ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up